These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 19995151)
61. Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiol. Davis SR; Simpson ER; Kuhl H; Wiegratz I Menopause; 2003; 10(1):105-6; author reply 106-7. PubMed ID: 12544685 [No Abstract] [Full Text] [Related]
62. Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiol. Egarter C; Kuhl H; Wiegratz I Menopause; 2003; 10(1):102-3; author reply 103-5. PubMed ID: 12544684 [No Abstract] [Full Text] [Related]
63. Replacing hormones, understanding the consequences. Heiman JR Menopause; 2002; 9(3):153-5. PubMed ID: 11973437 [No Abstract] [Full Text] [Related]
64. Tibolone revisited: still a good treatment option for healthy, early postmenopausal women. Kenemans P Gynecol Endocrinol; 2010 Apr; 26(4):237-9. PubMed ID: 20017707 [No Abstract] [Full Text] [Related]
65. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769 [TBL] [Abstract][Full Text] [Related]
66. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France]. Jamin C; Bourg F; Legeai J; Senoussi S Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401 [TBL] [Abstract][Full Text] [Related]
67. Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke. de Melo NR; Pompei LM Gynecol Endocrinol; 2010 Feb; 26(2):73-5. PubMed ID: 19995151 [No Abstract] [Full Text] [Related]
68. Tibolone: the way to beat many a postmenopausal ailments. Lazovic G; Radivojevic U; Marinkovic J Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345 [TBL] [Abstract][Full Text] [Related]
69. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Biglia N; Maffei S; Lello S; Nappi RE Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550 [TBL] [Abstract][Full Text] [Related]
70. Effects of tibolone on the breast of postmenopausal women. Wang PH; Cheng MH; Chao HT; Chao KC Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619 [TBL] [Abstract][Full Text] [Related]
71. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Campisi R; Marengo FD Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936 [TBL] [Abstract][Full Text] [Related]